Lethal toxicity of uracil/tegafur in the treatment of sigmoid carcinoma.
Bosch
T M
TM
Meijerman
I
I
Beijnen
J H
JH
van Thiel
S W
SW
Vlasveld
L T
LT
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000378:metabolism; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics / Q000378:metabolism; D065637:Cytochrome P-450 CYP2A6; D020345:Enterocolitis, Necrotizing / Q000139:chemically induced* / Q000150:complications; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D006899:Mixed Function Oxygenases / Q000235:genetics / Q000378:metabolism; D009102:Multiple Organ Failure / Q000209:etiology*; D020641:Polymorphism, Single Nucleotide; D018805:Sepsis / Q000150:complications / Q000209:etiology*; D012811:Sigmoid Neoplasms / Q000188:drug therapy*; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D005641:Tegafur; D014498:Uracil; D006899:Mixed Function Oxygenases; D001189:Aryl Hydrocarbon Hydroxylases; D065637:Cytochrome P-450 CYP2A6